Fierce Pharma

MAY 2, 2023

Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets kdunleavy Tue, 05/02/2023 - 09:27

Sales 299

Sales 299

MedCity News

MAY 2, 2023

Through Morgan Health’s $25 million investment, Kindbody will continue expanding into new markets. It will also grow its services, including menopause treatment and male fertility.

Marketing 104

Marketing 104

Fierce Pharma

MAY 2, 2023

GSK staffers kick off series of strikes in UK for the first time in drugmaker's history aliu Tue, 05/02/2023 - 14:22

264

264

PharmaVoice

MAY 2, 2023

What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

Pharma 105

Pharma 105

Advertisement

Distribution

Fierce Pharma

MAY 2, 2023

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen zbecker Tue, 05/02/2023 - 16:34

222

222

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 1,2 In the EU, an estimated 2.7 million people are diagnosed with cancer annually and the number is growing. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients.

Patients 101

Patients Medicine Marketing Medical 101

MedCity News

MAY 2, 2023

Feedtrail believes healthcare workers become more satisfied in their roles when they’re connected to messages of patient gratitude, so it built technology to deliver that positive feedback to clinicians. The company recently announced the results of a five-month clinician retention workgroup, finding that 77% of clinicians agreed that consistently receiving positive patient messages reinforced their purpose.

Patients 100

Patients Healthcare Healthcare Physicians 100

Fierce Pharma

MAY 2, 2023

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market kdunleavy Tue, 05/02/2023 - 06:53

Marketing 212

Marketing FDA 212

Pharmaceutical Technology

MAY 2, 2023

The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application submitted by Bristol Myers Squibb for Reblozyl (luspatercept-aamt) as a first-line treatment of anaemia in adults with lower-risk myelodysplastic syndromes (MDS). The regulatory body has also granted priority review to the application and set 28 August 2023 as a target date for the prescription drug user fee act (PDUFA).

Food and Drug Administration 98

Food and Drug Administration FDA Safety Prescription 98

Fierce Pharma

MAY 2, 2023

Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again zbecker Tue, 05/02/2023 - 10:54

183

183

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Medgadget

MAY 2, 2023

Engineers at MIT have developed a patch that uses ultrasound to deliver drugs through the skin. Ultrasound can create temporary openings in skin, allowing drugs to pass through. The skin is typically a difficult area for drug delivery, as it forms a tough barrier. However, the patch, which contains piezoelectric transducers, can push drugs through the skin highly efficiently.

Engineering 98

Engineering Leads Medicine 98

Fierce Pharma

MAY 2, 2023

Merck entitled to $1.

Insurance 311

Insurance 311

PharmaVoice

MAY 2, 2023

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

97

97

MedCity News

MAY 2, 2023

Out of 59.82 million people with Medicare Part A and Part B in January 2023, 30.19 million people were enrolled in Medicare Advantage plans, the Kaiser Family Foundation found in a recent analysis.

97

97

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Medgadget

MAY 2, 2023

Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of myeloid white blood cells, and then modifying them with ‘backpacks’ that contain anti-inflammatory molecules. The modified cells can then be administered back to the patient, and the backpack ensures that they maintain an anti-inflammatory phenotype.

Side effects 91

Side effects Patients Medicine 91

MedCity News

MAY 2, 2023

Sparsentan failed to meet the main goal of a Phase 3 test in focal segmental glomerulosclerosis (FSGS). Nevertheless, Travere Therapeutics says the totality of data points to patient improvement in the rare kidney disorder and the biotech will talk with regulators about a potential path forward.

Patients 91

Patients Biopharma Pharma 91

Copyright Clearance Center

MAY 2, 2023

May 2, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will present a Town Hall discussion via LinkedIn Live on 10 May at 11:00 a.m. EDT/16:00 BST/17:00 CEST where a VIP panel will share best practices for developing research data that is FAIR through culture, training, and technology. Audience members will learn how to identify signals of improvement and create breakthrough interoperability across research domains.

Government 91

Government Training Management Leads 91

Scott Burrows

MAY 2, 2023

It is Time to Get Accountable about Safety As a motivational safety team speaker, I am familiar with the many recent studies on isolation and loneliness.

Safety 98

Safety 98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

MedCity News

MAY 2, 2023

Johnson & Johnson is acquiring rights to two next-generation cell therapies from Cellular Biomedicines, both potential treatments for diffuse large B-cell lymphoma. One therapy is already in the clinic while the other is on track to begin human testing this year.

Biopharma 89

Biopharma Pharma 89

European Pharmaceutical Review

MAY 2, 2023

The US Food and Drug Administration (FDA) has released a new draft guidance to further support the use of decentralised clinical trials (DCTs) for drugs, biologics and devices. The publication includes recommendations for sponsors, investigators and other stakeholders regarding the implementation of DCTs to advance medical product development and research.

FDA 81

FDA Food and Drug Administration Medical Food 81

MedCity News

MAY 2, 2023

Kinnos — a startup reimagining the way hospitals disinfect their surfaces by colorizing the process — recently raised $15 million in financing. Through better sanitization practices, the company is seeking to decrease hospital-acquired infections, which cause 72,000 deaths every year.

82

82

Medgadget

MAY 2, 2023

Researchers at Rice University have developed a “Stimu Sock” that can help to treat balance issues and pain in the feet caused by diabetic neuropathy. The socks contain an insole that can provide haptic feedback if someone is overbalancing, helping them to correct things. It can also administer transcutaneous electrical nerve stimulation that can help to reduce pain in the feet.

Engineering 76

Engineering Patients Leads Competition 76

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaTech

MAY 2, 2023

The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.

98

98

MedReps

MAY 2, 2023

Getting into medical device sales requires quite a bit of knowledge. Many employers, unless the job is for entry-level sales, want to see what type of experience you have in the field as well. Add in the fact that human resources workers and recruiters tend to quickly view your resume looking for specific keywords, and you have a short amount of time to prove your expertise in the field.

Medical sales 70

Medical sales Medical Sales Product Knowledge 70

Copyright Clearance Center

MAY 2, 2023

The post 5 Questions for Linguamatics’ Jane Reed appeared first on Copyright Clearance Center.

97

97

PharmExec

MAY 2, 2023

Acquisition expected to support pharmaceutical’s blindness regeneration campaign.

98

98

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. The round was led by Threshold Ventures and co-led by Monograph Capital. Another new investor to take part in Series B round was Wittington Ventures. Existing investors including Flint Capital, StandUp Ventures, Graphite Ventures and BDC Capital’s Women in Technology Venture Fund, also participated in this round.

Pharma 59

Pharma Pharmaceutical Sales Healthcare Provider Prospecting 59

PharmaTech

MAY 2, 2023

Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing.

Manufacturing 69

Manufacturing Pharma 69

Scott Burrows

MAY 2, 2023

It is Time to Get Accountable about Safety As a motivational safety team speaker , I am familiar with the many recent studies on isolation and loneliness. If you’re currently scratching your head as to what loneliness might have to do with safety, just stay with me for a moment as we move through this article from the Harvard Business Review: “Our study substantiated existing evidence that exclusion is a growing issue.

Safety 52

Safety Manufacturing Healthcare Healthcare 52

Contrarian Sales Techniques

MAY 2, 2023

It's the Salesperson, Not the Strategies As a salesperson, I've always been fascinated by the idea of finding the perfect sales strategy or tactic that will guarantee success. Over the years, I've read countless books, attended numerous trainings, and tried all sorts of approaches to improve my sales performance. And while I've had my fair share of wins and losses, one thing I've come to realize is this: it's not the sales strategies or tactics that make the biggest difference – it's the salespe

Sales 52

Sales Sales Strategy Training Prospecting 52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management